StockWatch
·
Pharmaceuticals
AGM/EGM8 Sept 2026, 04:08 pm

Everest Organics Reports Profitability in FY26, Revenue Up 23%

AI Summary

Everest Organics Ltd has announced its 33rd Annual Report for FY 2025-26, marking a significant financial turnaround. The company reported a total revenue of ₹19,740.42 Lakhs, a 23% increase from the previous year's ₹16,016.59 Lakhs. Profit Before Tax (PBT) turned positive at ₹804.67 Lakhs, reversing a loss of ₹324.26 Lakhs in FY 2024-25. Net Profit for FY26 stood at ₹554.65 Lakhs, compared to a Net Loss of ₹129.03 Lakhs in the prior year, with Earnings Per Share (EPS) at ₹5.70. The company has not recommended a dividend, opting to reinvest earnings to strengthen reserves and surplus to ₹6,576.77 Lakhs. Everest Organics is also investing in expanding its manufacturing capacity for APIs and Intermediates, securing an Environmental Clearance Certificate and pursuing further approvals. The 33rd Annual General Meeting (AGM) is scheduled for September 30, 2026, with e-voting available from September 27-29, 2026.

Key Highlights

  • FY26 revenue grew 23% to ₹19,740.42 Lakhs.
  • Company returned to profitability with Net Profit of ₹554.65 Lakhs.
  • Reserves and surplus strengthened to ₹6,576.77 Lakhs.
  • AGM scheduled for September 30, 2026, with e-voting window.
  • Manufacturing capacity expansion underway for APIs and Intermediates.